Pennsylvania-based Mylan Pharmaceutical, one of the largest global manufacturers of generic and specialty drugs will be laying off 500 employees, approximately 15% of its workforce, in Morgantown, West Virginia. The layoffs will be mostly in operations.
According to a company spokesperson …
“We believe our plant in Morgantown is one of the largest pharmaceutical manufacturing facilities in the world. As the industry has changed and regulatory expectations have continued to evolve, we’ve realized that our Morgantown plant needed to be right-sized to be less complex. The right-sizing is consistent with discussions we are having with the U.S. Food and Drug Administration and is necessary in order to position the site as best we can for continued operations. We remain committed to a U.S. manufacturing base and plan to continue making the majority of the medicines we supply to the U.S in the U.S.” Mylan has been operating in Morgantown for nearly 60 years and will still remain one of West Virginia’s largest employees with approximately 3,000 remaining employees.
The union response ...
Howard Martin, United Steel Workers Local 8-957 President commented, "Currently the union leadership is working with the company, trying to finalize a voluntary separation program, doing this to offset and hopefully be able to bring some people back. Hopefully we'll get that wrapped up next week and the company can present that as an option to the members."
Mylan has suffered financially since 2016 when the politicians and public reacted in outrage at its pricing for its EpiPen autoinjectors used in to inject epinephrine (adrenaline) under emergency conditions. a life-saving allergic reaction. Mylan neither admitted nor denied that it mischarged Medicaid and agreed to a $465 million settlement. Mylan also implemented a half-price authorized generic of EpiPen
Are you asking yourself, Am I Next?